期刊文献+

中医序贯疗法辅助化疗治疗难治性急性髓系白血病疗效观察 被引量:3

下载PDF
导出
摘要 急性白血病的难治是导致治疗失败的最主要因素之一。现代医学采取不断增加化疗的强度、交替序贯更换化疗方案、配合防治逆转耐药的药物,乃至造血干细胞移植的技术,但仍然有相当部分患者难于避免地出现难治,导致治疗的失败。通过实验研究及临床单一的初步观察,某些中成药有抗白血病增殖、防治多药耐药、生物反应调节等作用。我们在临床率先采取中医序贯综合疗法治疗,达到增效减毒目的,提高了临床疗效。现对临床资料进行分析报道如下。
出处 《深圳中西医结合杂志》 2007年第2期118-119,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献8

二级参考文献53

共引文献331

同被引文献35

  • 1李达,杨淑莲,梁冰.中西医结合治疗急性非淋巴细胞性白血病82例临床观察[J].山西中医,1995,11(6):20-21. 被引量:4
  • 2刘琨,李达,张宏业.87例多发性骨髓瘤的中医证型分析[J].新中医,2007,39(8):57-58. 被引量:15
  • 3National Cancer Institute.SEER Stat Fact Sheets:Acute Myeloid Leukemia.Bethsda,MD:2011.
  • 4Menzin J,Lang K,Earle C C,et al.The outcomes and costs of acute myeloid leukemia among the elderly.Arch Intern Med,2002,162( 14): 1597-1603.
  • 5O'Donnell M R,Abboud C N,Ahman J,et al.Acute myeloid leukemia.Nat] Compr Canc Netw,2012,10(8):984-1021.
  • 6Lowenberg B,Ossenkoppele G J,van Pntten W,et al.High-dose daunorubicin in older patients with arcute myeloid leukemia.N Engl J Med,2009,361 (13): 1235-1248.
  • 7Brunnberg U,Mohr M,Noppeney R,et al.Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin:a randomized phase II trial in elderly patients.Ann Oncol,2012,23 (4):990-996.
  • 8Quint~is-Cardama A,Ravandi F,Liu-Dumlao T,et al.Epigenetic therapy is associated with similar survival comlcared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia.Blood,2012,120(24):4840-4845.
  • 9DOhner H,Estey E H,Amadori S,et al.Diagnosis and management of acute myeloid leukemia in adults:recommendations from an intemational expertpanel,on behalf of the European Leukemia Net. Blood,2010,115(3):453-474.
  • 10Roboz G J,Wissa U,Ritehie E K,et al.Are low-intensity induction strategies better for older patients with acute myeloid leukemia?Leuk Res,2012,36(4):407-4 12.

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部